{"icp":"Biopharmaceutical companies and healthcare providers focused on innovative treatments for serious diseases.","faqs":[{"answer":"CRISPR Therapeutics is a biotechnology company focused on developing gene-based medicines using CRISPR technology to treat serious diseases.","question":"What is CRISPR Therapeutics?"},{"answer":"The company targets a range of diseases including hemoglobinopathies, oncology, diabetes, and cardiovascular diseases.","question":"What diseases does CRISPR Therapeutics target?"},{"answer":"The first approved CRISPR-based therapy is CASGEVY™ (exagamglogene autotemcel), which is used for treating sickle cell disease and transfusion-dependent beta thalassemia.","question":"What is the first approved CRISPR-based therapy?"},{"answer":"The global headquarters is located in Zug, Switzerland, with additional R&D facilities in Boston, MA, and Framingham, MA.","question":"Where is CRISPR Therapeutics headquartered?"},{"answer":"CRISPR technology allows for precise editing of genes, enabling the development of therapies that can correct genetic defects and treat diseases.","question":"How does CRISPR technology work?"}],"pricing":{"price_model":"unknown","price_notes":"Pricing information is not available on the website.","has_free_tier":false,"starting_price":null},"version":"1.0","category":"Biotechnology","features":["Gene editing technology","Development of gene-based therapies","Clinical programs for various diseases","Patient advocacy initiatives","State-of-the-art manufacturing facilities"],"verified":false,"offerings":[{"name":"Gene-Based Medicines","type":"product_line","description":"Therapies developed using CRISPR technology to treat serious diseases, including hemoglobinopathies, oncology, autoimmune diseases, and more."},{"name":"CRISPR/Cas9 Therapy","type":"product_line","description":"The first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia."}],"brand_name":"CRISPR Therapeutics","schema_url":"https://useharbor.io/brands/crispr-therapeutics/harbor.json","enriched_at":"2025-12-13T06:40:33.436Z","company_info":{"hq_location":"Zug, Switzerland","founded_year":2013,"employee_band":"201-1000","industry_tags":["Biotechnology","Gene Editing","Pharmaceuticals"]},"generated_at":"2025-12-13T06:40:33.436Z","integrations":[],"one_line_summary":"Pioneering gene-based medicines to transform the lives of patients with serious diseases.","short_description":"CRISPR Therapeutics is at the forefront of gene editing technology, focusing on developing transformative therapies for serious diseases such as sickle cell disease and cancer. With a diverse portfolio of programs, the company aims to revolutionize medicine through innovative gene-based treatments.","enrichment_version":"1.0","visibility_scoring":{"score_rationale":"The website clearly outlines the company's mission, offerings, and areas of focus, providing comprehensive information that is well-structured for AI extraction.","brand_clarity_0_25":25,"structure_for_ai_0_20":20,"trust_and_basics_0_20":20,"offerings_clarity_0_25":25,"breadth_of_coverage_0_10":10,"total_visibility_score_0_100":100}}